Skip to main content
VCbacked
Log inGet Started

Hervolution Therapeutics

Copenhagen, Denmark

Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).

$11.7M raised
Dec 2024
Series A
BiopharmaBiotechnologyGenetics

Top Investors

European Innovation CouncilSerum Institute of India Pvt. Ltd.

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Hervolution Therapeutics

How much funding has Hervolution Therapeutics raised?
Hervolution Therapeutics has raised $11.7M in total funding. The most recent round was Series A. The last funding was announced in December 2024.
Who are Hervolution Therapeutics's investors?
Hervolution Therapeutics's investors include European Innovation Council, Serum Institute of India Pvt. Ltd..
Where is Hervolution Therapeutics headquartered?
Hervolution Therapeutics is headquartered in Copenhagen, Denmark.
What does Hervolution Therapeutics do?
Hervolution Therapeutics develops immunotherapies targeting tumors using Human Endogenous Retroviral proteins (HERVs).
What stage is Hervolution Therapeutics at?
Hervolution Therapeutics is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Hervolution Therapeutics — Funding & Investors." VCBacked, December 19, 2024, https://www.vcbacked.co/company/hervolution-therapeutics. Accessed June 4, 2026.
APA
VCBacked. (2024). Hervolution Therapeutics — Funding & Investors. Retrieved June 4, 2026, from https://www.vcbacked.co/company/hervolution-therapeutics
Wikipedia (cite web)
{{cite web |title=Hervolution Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/hervolution-therapeutics |website=VCBacked |access-date=June 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biopharma

View all
ParcelBio
San Francisco$13.2M
Modicus Prime
Austin
Latus Bio
Philadelphia
Ocugen
Malvern
Ember LifeSciences
Los Angeles$16.5M
ClearNote Health
San Diego